What does Squadron Capital Management LLC hold? Q4 2025 13F Holdings & Portfolio

AI Analysis · Q4 2025 · Q4 2025

Squadron Capital Management LLC filed its latest 13F-HR for Q4 2025. See the latest holdings and position changes below.

Quarter at a glance — Q4 2025

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q4 2025.

#HoldingValueSharesWeight

RELMADA THERAPEUTICS INC

$32M6.7M13.7%

COGENT BIOSCIENCES INC

$28M780K11.7%

MAZE THERAPEUTICS INC

$20M490K8.6%

ABIVAX SA

$20M145K8.3%

KALVISTA PHARMACEUTICALS INC

$11M700K4.8%

PALISADE BIO INC

$11M4.5M4.5%

EDGEWISE THERAPEUTICS INC

$9M350K3.7%

INHIBIKASE THERAPEUTICS INC

$9M4.2M3.7%

KODIAK SCIENCES INC

$8M292K3.5%

TERNS PHARMACEUTICALS INC

$8M190K3.3%

Filing history loading…